Literature DB >> 18825407

Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas.

Aurélie Capouillez1, Christine Decaestecker, Olivier Filleul, Dominique Chevalier, Frederique Coppée, Xavier Leroy, Alexandra Belayew, Sven Saussez.   

Abstract

The helicase-like transcription factor (HLTF) belongs to the SWI/SNF family of proteins that use the energy from adenosine triphosphate hydrolysis to remodel chromatin during a variety of cellular processes. HLTF is also involved in DNA repair. Using computer-assisted microscopy, the immunohistochemical expression of HLTF was determined using a series of 100 hypopharyngeal and 56 laryngeal squamous cell carcinomas (SCCs) compared to tumor-free epithelia (60 cases) and dysplasias (92 cases). In hypopharyngeal SCC tumor progression, increased HLTF expression was associated with the percentage of immunopositive epithelial tissue areas (p = 0.02) and the staining intensity of the positive area (p = 0.0005). In the cases of laryngeal lesions, the immunolabeling intensity of HLTF significantly decreased with malignancy (p = 0.01). We also observed a significant shift of HLTF expression from the cytoplasm toward the nuclear compartment (p = 0.0007). Our data reveal an association between the presence of HLTF and neoplastic progression of hypopharyngeal and laryngeal SCCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825407     DOI: 10.1007/s00428-008-0675-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Cloning and characterization of an atypical Type IV P-type ATPase that binds to the RING motif of RUSH transcription factors.

Authors:  M Mansharamani; A Hewetson; B S Chilton
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

2.  Lymphatic vessel density, nodal metastases, and prognosis in patients with head and neck cancer.

Authors:  Nathalie Audet; Nigel J Beasley; Christina MacMillan; David G Jackson; Patrick J Gullane; Suzanne Kamel-Reid
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-12

3.  HLTF gene silencing in human colon cancer.

Authors:  Helen R Moinova; Wei-Dong Chen; Lanlan Shen; Dominic Smiraglia; Joseph Olechnowicz; Lakshmeswari Ravi; Lakshmi Kasturi; Lois Myeroff; Christoph Plass; Ramon Parsons; John Minna; James K V Willson; Sylvan B Green; Jean-Pierre Issa; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis.

Authors:  Kenji Hibi; Yasuhiro Kodera; Katsuki Ito; Seiji Akiyama; Akimasa Nakao
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

5.  Methylation pattern of HLTF gene in digestive tract cancers.

Authors:  Kenji Hibi; Hiroshi Nakayama; Yasuaki Kanyama; Yasuhiro Kodera; Katsuki Ito; Seiji Akiyama; Akimasa Nakao
Journal:  Int J Cancer       Date:  2003-04-20       Impact factor: 7.396

6.  Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history.

Authors:  J J Kim; S W Chung; J H Kim; J W Kim; J S Oh; S Kim; S Y Song; J Park; D-H Kim
Journal:  Ann Oncol       Date:  2006-02-23       Impact factor: 32.976

7.  Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.

Authors:  Wai K Leung; Jun Yu; Alfa H C Bai; Michael W Y Chan; Ka-Kui Chan; Ka-Fai To; Francis K L Chan; Enders K W Ng; S C Sydney Chung; Joseph J Y Sung
Journal:  Mol Carcinog       Date:  2003-06       Impact factor: 4.784

8.  Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination.

Authors:  Ildiko Unk; Ildikó Hajdú; Károly Fátyol; Jerard Hurwitz; Jung-Hoon Yoon; Louise Prakash; Satya Prakash; Lajos Haracska
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

9.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

10.  Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis.

Authors:  Gaël Debauve; Denis Nonclercq; Fabrice Ribaucour; Murielle Wiedig; Cécile Gerbaux; Oberdan Leo; Guy Laurent; Fabrice Journé; Alexandra Belayew; Gérard Toubeau
Journal:  Mol Cancer       Date:  2006-06-08       Impact factor: 27.401

View more
  5 in total

1.  Rad5 dysregulation drives hyperactive recombination at replication forks resulting in cisplatin sensitivity and genome instability.

Authors:  Eric E Bryant; Ivana Šunjevarić; Luke Berchowitz; Rodney Rothstein; Robert J D Reid
Journal:  Nucleic Acids Res       Date:  2019-09-26       Impact factor: 16.971

Review 2.  The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?

Authors:  Ludovic Dhont; Céline Mascaux; Alexandra Belayew
Journal:  Cell Mol Life Sci       Date:  2016-01       Impact factor: 9.261

3.  Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.

Authors:  Chi Keung Cheng; Natalie P H Chan; Thomas S K Wan; Lai Ying Lam; Coty H Y Cheung; Terry H Y Wong; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

4.  Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC).

Authors:  Ludovic Dhont; Melania Pintilie; Ethan Kaufman; Roya Navab; Shirley Tam; Arsène Burny; Frances Shepherd; Alexandra Belayew; Ming-Sound Tsao; Céline Mascaux
Journal:  BMC Cancer       Date:  2018-04-16       Impact factor: 4.430

5.  Differential genomics and transcriptomics between tyrosine kinase inhibitor-sensitive and -resistant BCR-ABL-dependent chronic myeloid leukemia.

Authors:  Neetu Singh; Anil Kumar Tripathi; Dinesh Kumar Sahu; Archana Mishra; Margaret Linan; Bianca Argente; Julia Varkey; Niranjan Parida; Rebecca Chowdhry; Hari Shyam; Nawazish Alam; Shivani Dixit; Pratap Shankar; Abhishek Mishra; Avinash Agarwal; Chris Yoo; Madan Lal Brahma Bhatt; Ravi Kant
Journal:  Oncotarget       Date:  2018-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.